Zoledronic Acid
Tocris Bioscience, part of Bio-Techne | Catalog # 6111
Potent farnesyl diphosphate (FPP) synthase inhibitor
Key Product Details
Description
Potent farnesyl diphosphate (FPP) synthase inhibitor
Alternative Names
Zometa
Product Description
Zoledronic Acid is a potent bisphophonate farnesyl diphosphate (FPP) synthase inhibitor (IC50 = 20 nM). Inhibits osteoclast-mediated bone resorption. Also inhibits Ras signaling and tumor growth, and induces apoptosis in pancreatic cancer cells. Reverses epithelial-mesenchymal transition and inhibits breast cancer cell renewal via inactivation of NF-κB.Product Specifications
Molecular Weight
272.09
Formula
C5H10N2O7P2
Storage
Store at +4°C
Purity
≥98% (HPLC)
Chemical Name
[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic acid
CAS Number
118072-93-8
PubChem ID
68740
InChI Key
XRASPMIURGNCCH-UHFFFAOYSA-N
SMILES
OC(P(O)(O)=O)(P(O)(O)=O)CN1C=CN=C1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| 1.1eq. NaOH | 13.6 | 50 | |
| water | 0.68 | 2.5 |
Preparing Stock Solutions
for Zoledronic Acid
The following data is based on the product molecular weight 272.09
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 7.35 mL | 36.75 mL | 73.51 mL |
| 2.5 mM | 1.47 mL | 7.35 mL | 14.70 mL |
| 5 mM | 0.74 mL | 3.68 mL | 7.35 mL |
| 25 mM | 0.15 mL | 0.74 mL | 1.47 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Tassone Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Br.J.Cancer 2003 PMID: 12799645
- Dunford Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J.Pharmacol.Exp.Ther. 2001 PMID: 11160603
- Schech Zoledronic acid reverses the epithelial-mesenchymal transition and inhibits self-renewal of breast cancer cells through inactivation of NF-κB. Mol.Cancer Ther. 2013 PMID: 23619300
Product Specific Notices for Zoledronic Acid
For research use only
Loading...
Loading...